why choose us

First received: April 12, 2023

Clinical Trial: RewinD-LB - Clinical Study of Neflamapimod in Patients With Dementia With Lewy Bodies

Study Status: Completed

Recruit Status: RECRUITING

Condition: Dementia With Lewy Bodies

Study Type: INTERVENTIONAL


Official Title: A Phase 2b Clinical Study of the P38 Alpha Kinase Inhibitor Neflamapimod in Patients With Dementia With Lewy Bodies

Brief Summary: The purpose of this study is to determine whether neflamapimod can improve learning skills, problem solving skills, and memory loss in people diagnosed with DLB.More specifically, improvement in verbal learning, memory, and attention, as well as cognitive and functional performance will be measured.

Read more